A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection
Clinical trial NCT05472090 · COMPLETED
Trial details
- NCT number
- NCT05472090
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2023-07-12
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.